We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$334M
AUM Growth
+$47.3M
Cap. Flow
+$13.4M
Cap. Flow %
4.02%
Top 10 Hldgs %
23.72%
Holding
289
New
27
Increased
129
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.41M
2
CVS icon
CVS Health
CVS
+$1.67M
3
WFC icon
Wells Fargo
WFC
+$1.58M
4
TGT icon
Target
TGT
+$1.34M
5
ABBV icon
AbbVie
ABBV
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.34%
2 Technology 13%
3 Industrials 10.2%
4 Financials 9.85%
5 Energy 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$624B
$13.2M 3.96%
94,480
-1,592
-2% -$213K
AAPL icon
2
Apple
AAPL
$4.72T
$10.1M 3.01%
211,828
+17,420
+9% +$739K
XOM icon
3
ExxonMobil
XOM
$650B
$9.96M 2.98%
123,282
-6,720
-5% -$512K
MSFT icon
4
Microsoft
MSFT
$2.83T
$8.52M 2.55%
72,241
+4,573
+7% +$499K
PEP icon
5
PepsiCo
PEP
$184B
$6.79M 2.03%
55,393
-1,234
-2% -$141K
T icon
6
AT&T
T
$160B
$6.64M 1.99%
280,393
+50,274
+22% +$1.16M
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.06T
$6.49M 1.94%
32,295
+1,389
+4% +$280K
JPM icon
8
JPMorgan Chase
JPM
$930B
$6.27M 1.88%
61,959
+11,134
+22% +$1.15M
VZ icon
9
Verizon
VZ
$183B
$6.2M 1.86%
104,848
-1,672
-2% -$94.7K
HD icon
10
Home Depot
HD
$324B
$5.08M 1.52%
26,458
+1,227
+5% +$225K
ABBV icon
11
AbbVie
ABBV
$454B
$4.95M 1.48%
61,468
+15,857
+35% +$1.3M
PG icon
12
Procter & Gamble
PG
$342B
$4.61M 1.38%
44,303
+197
+0.4% +$19.2K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.88T
$4.54M 1.36%
77,360
+8,920
+13% +$500K
ABT icon
14
Abbott
ABT
$175B
$4.37M 1.31%
54,624
+346
+0.6% +$25.7K
CVX icon
15
Chevron
CVX
$387B
$4.27M 1.28%
34,649
+1,600
+5% +$189K
CVS icon
16
CVS Health
CVS
$136B
$4.09M 1.22%
75,828
+27,074
+56% +$1.67M
BDX icon
17
Becton Dickinson
BDX
$42.1B
$3.98M 1.19%
16,345
+1,025
+7% +$242K
IBM icon
18
IBM
IBM
$194B
$3.55M 1.06%
26,302
-1,810
-6% -$231K
EPD icon
19
Enterprise Products Partners
EPD
$83.9B
$3.4M 1.02%
116,947
+15,529
+15% +$434K
PFE icon
20
Pfizer
PFE
$143B
$3.36M 1.01%
83,362
-1,998
-2% -$80K
EMR icon
21
Emerson Electric
EMR
$81.2B
$3.34M 1%
48,813
+233
+0.5% +$15.3K
VEA icon
22
Vanguard FTSE Developed Markets ETF
VEA
$226B
$3.32M 0.99%
81,141
+60,267
+289% +$2.41M
HON icon
23
Honeywell
HON
$78B
$3.21M 0.96%
21,405
+411
+2% +$57.4K
MRK icon
24
Merck
MRK
$322B
$2.95M 0.88%
37,124
-234
-0.6% -$17.5K
MCD icon
25
McDonald's
MCD
$187B
$2.9M 0.87%
15,282
+486
+3% +$88.2K

Similar funds

Boenning & Scattergood's Q1 2019 Portfolio in Review

As of Q1 2019, Boenning & Scattergood held 289 positions worth $334M, up 17% from $287M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $13.4M of net new capital in Q1 2019, opening 27 new positions and adding to 129 existing holdings. Its largest new stake was Target: 18,390 shares worth $1.48M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Universal Health Realty Income Trust, an estimated $5.13M trimmed.

  • Boenning & Scattergood's largest Q1 2019 buy was Target: 18,390 shares worth $1.48M.
  • Boenning & Scattergood added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $2.41M increase.
  • Boenning & Scattergood's biggest Q1 2019 reduction was Universal Health Realty Income Trust, cutting an estimated $5.13M.
  • Boenning & Scattergood fully exited iShares Biotechnology ETF in Q1 2019, selling an estimated $1.13M.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $334M portfolio in Q1 2019.
  • Boenning & Scattergood opened 27 new positions and closed 9 in Q1 2019.
  • Boenning & Scattergood's portfolio value rose 17% quarter-over-quarter to $334M.

Based on Boenning & Scattergood's 13F filing for Q1 2019, filed 22 Apr 2019.